documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

7 rows where docket_id = "FDA-2026-P-1794" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)

document_type 2

posted_year 1

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2026-P-1794-0001 FDA None FDA-2026-P-1794 Suitability Petition from Lachman Consulting Services, Inc. Other Petition(s) 2026-02-18T05:00:00Z 2026 2 2026-02-18T05:00:00Z   2026-02-19T01:50:40Z   1 0 09000064b91b9267
FDA-2026-P-1794-0002 FDA None FDA-2026-P-1794 Acknowledgment Letter from FDA DMB to Lachman Consulting Services, Inc. Other Acknowledgement Letter/Receipt 2026-02-18T05:00:00Z 2026 2 2026-02-18T05:00:00Z   2026-02-19T01:50:46Z   0 0 09000064b91b9269
FDA-2026-P-1794-0007 FDA None FDA-2026-P-1794 Attachment 5 Advances in Therapy Supporting & Related Material Background Material 2026-02-18T05:00:00Z 2026 2     2026-02-19T01:52:47Z   0 0 09000064b91bb01b
FDA-2026-P-1794-0004 FDA None FDA-2026-P-1794 Attachment 2 Current Package Insert for Xarelto Supporting & Related Material Background Material 2026-02-18T05:00:00Z 2026 2     2026-02-19T01:52:36Z   0 0 09000064b91b9bfd
FDA-2026-P-1794-0006 FDA None FDA-2026-P-1794 Attachment 4 Blood Advances Supporting & Related Material Background Material 2026-02-18T05:00:00Z 2026 2     2026-02-19T01:52:44Z   0 0 09000064b91bb01a
FDA-2026-P-1794-0005 FDA None FDA-2026-P-1794 Attachment 3 Proposed Package Insert Rivaroxaban ODT Supporting & Related Material Background Material 2026-02-18T05:00:00Z 2026 2     2026-02-19T01:52:40Z   0 0 09000064b91b9bfe
FDA-2026-P-1794-0003 FDA None FDA-2026-P-1794 Attachment 1 Copy of Current Orange Book Listing for RLD Xarelto Supporting & Related Material Background Material 2026-02-18T05:00:00Z 2026 2     2026-02-19T01:52:31Z   0 0 09000064b91b9bfc

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;